Ontology highlight
ABSTRACT:
SUBMITTER: Holanek M
PROVIDER: S-EPMC9318288 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
Holanek Milos M Selingerova Iveta I Fabian Pavel P Coufal Oldrich O Zapletal Ondrej O Petrakova Katarina K Kazda Tomas T Hrstka Roman R Poprach Alexandr A Zvarikova Maria M Bilek Ondrej O Svoboda Marek M
Diagnostics (Basel, Switzerland) 20220718 7
A residual cancer burden after neoadjuvant therapy (NAT) for breast cancer (BC) is associated with worse treatment outcomes compared to patients who achieved pathologic complete remission. This single-institutional retrospective study of 767 consecutive patients, including 468 patients with assessable residual cancer burden (aRCB) after NAT, with a median follow-up of 36 months, evaluated the biomarkers assessed before NAT from a biopsy and after NAT from a surgical specimen, their dynamics, and ...[more]